Issue 17, 2022

CRISPR/Cas12a-based fluorescence immunoassay: combination of efficient signal generation with specific molecule recognition

Abstract

Using the DNA activator of Cas to label the secondary antibody of traditional ELISA, the CRISPR/Cas12a-based fluorescence immunoassay was presented. The sensing strategy ingeniously combines the efficient signal generation of the CRISPR/Cas12a system with antigen–antibody-specific recognition. This work provides an alternative strategy to expand the application of the CRISPR/Cas system for the detection of non-nucleic acid targets.

Graphical abstract: CRISPR/Cas12a-based fluorescence immunoassay: combination of efficient signal generation with specific molecule recognition

Supplementary files

Article information

Article type
Communication
Submitted
29 Jun 2022
Accepted
27 Jul 2022
First published
28 Jul 2022

Analyst, 2022,147, 3833-3837

CRISPR/Cas12a-based fluorescence immunoassay: combination of efficient signal generation with specific molecule recognition

X. Li, Y. Zhang, Q. Liu, Y. Jin and B. Li, Analyst, 2022, 147, 3833 DOI: 10.1039/D2AN01048H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements